Technical

Technical — what price action is saying

Lee & Man Chemical (0746.HK) has rallied sharply off the February 2024 low, notched a golden cross in July 2025, and then handed back roughly a quarter of those gains since the February 2026 peak. The short-term read: a post-rally pullback into the 50-day, with momentum freshly oversold but not broken. The medium-term read: the 200-day has finally turned higher, so the structural backdrop improved — it is the near-term tape that is now weak.

Liquidity caveat. This is a small-cap Hong Kong chlor-alkali ticker. Median daily turnover in the last year is in the low hundreds of thousands of shares, and recent sessions print well under HK$5M of value. Technical signals here are noisier than on a large-cap; treat every indicator with a wider tolerance than you would for an S&P 500 name. There is also no clean sector ETF for HK-listed chemicals, so relative-strength is shown versus SPY only — useful as a capital-flows anchor, not as a sector read.

1. Price snapshot

Price (HK$)

4.85

YTD return (%)

-7.4

1-year return (%)

36.2

52-week position (%)

47.8

Beta vs SPY (3y)

0.05

Last price HK$4.85, roughly midway between the HK$3.41 52-week low and the HK$6.42 52-week high. Beta versus SPY is effectively zero — Hong Kong small-caps move on mainland and local-liquidity factors, not US equity beta — so the 1-year +36% is almost entirely idiosyncratic.

2. Three-year price with 50 and 200-day SMAs

Loading...

Price is below the 200-day. Last close HK$4.85 versus the 200-day at HK$5.25 — the stock sits roughly 7.6% under its long-term average. This is a pullback inside an uptrend, not a downtrend: the 200-day itself is still rising, both moving averages are positively stacked, and the 50-day (HK$5.56) remains above the 200-day. Regime: post-breakout consolidation, with near-term risk that a failure to reclaim the 200-day turns this into a bearish lower high.

3. Relative strength vs SPY (3-year, rebased to 100)

Loading...
No HK-chemicals sector ETF is available in the staged data, so this is company versus the US broad market only. Read it as a capital-flows backdrop, not a sector-relative signal.

0746 spent roughly two years underperforming SPY by a wide margin — it bottomed at about 52 on the rebased index in early 2024 while SPY was at 120 — then ripped from mid-2025 into early 2026 to briefly draw even on a three-year basis. Since the February 2026 peak, SPY kept grinding to new highs while 0746 gave back 20 points, so the gap is re-widening against the stock in the short term. Idiosyncratic story first, US beta a distant second.

4. Momentum — RSI(14) and MACD histogram

Loading...
Loading...

RSI is 36 and the MACD histogram just flipped marginally positive after five negative weeks. That combination — RSI well off overbought but not yet at the sub-30 reset seen in April 2025 and March 2026 — says momentum is washed out, not capitulatory. Near-term (1–3 month) read: tradable bounce setup if HK$4.80 holds; loss of that level probably flushes RSI to the low-30s before buyers show up.

5. Volume and conviction

Loading...
Loading...
No Results

Every notable volume spike in the last year printed on an up day — the biggest single session was 2026-03-12, 6x the 50-day average on a +12% close. That is demand-driven, not distribution. The concern is in what came after: the 50-day volume average has since rolled over from roughly 690k back to 570k while price fell, meaning the pullback is happening on drying-up volume rather than aggressive selling. For a thinly-traded small-cap this is as much noise as it is signal — flag, don't over-weight.

6. Volatility regime (30-day realized, 3-year)

Loading...

10-year realized-vol bands: calm under 21% (p20), normal 21%–41% (p20–p80), stressed above 41% (p80). Current 30-day vol is 48.5% — sitting in the stressed band. Vol spent most of 2024 and early 2025 in the calm-to-normal zone, jumped during the July-September 2025 breakout rally, briefly cooled, and has now re-accelerated through the March-April 2026 pullback. The market is pricing in more day-to-day risk than the 10-year norm; sizing should reflect that.

7. Technical scorecard and stance

No Results

Stance — neutral, leaning constructive, on a 3-to-6 month horizon. The structural picture improved in 2025 (200-day turned up, golden cross on 2025-07-24, a full round-trip back to the SPY line) and the current drawdown is textbook post-rally digestion rather than a break. But price is below the 200-day, relative strength is fading again, and realized vol is in the stressed band — three reasons not to commit before confirmation. The two levels that define the view: a weekly close back above HK$5.25 (the 200-day) would confirm the pullback is over and re-open the HK$6.00+ zone; a close below HK$4.50 (beneath the April 2025 swing and the rising 200-day) would invalidate the uptrend and likely see a retest of the HK$3.90–HK$4.10 shelf. Size for illiquidity: a thinly-traded HK small-cap can move 10% on a single 600k-share print, and technicals deserve a wider margin of error here than on a large-cap.